ChangeLab-Changing Life Cancer Research and Molecular Biology Laboratories, Department of Biochemistry, Room NB302 Faculty of Basic Medical Sciences, University of Ibadan, Ibadan, Oyo, 200004, Nigeria.
Department of Cancer Immunology and Biotechnology, School of Medicine, University of Nottingham, Nottingham, NG7 2RD, UK.
BMC Pharmacol Toxicol. 2022 Oct 1;23(1):76. doi: 10.1186/s40360-022-00615-0.
Inadvertent exposure to furan and Pb is associated with hepatorenal abnormalities in humans and animals. It is perceived that these two chemical species may work in synergy to orchestrate liver and kidney damage. Against this background, we investigated the combined effect of furan and incremental lead (Pb) exposure on hepatorenal dysfunction. Wistar rats (n = 30; 150 g) were treated for 28 days accordingly: Control; FUR (8 mg/kg), PbAc (100 µg/L), FUR + PbAc (8 mg/kg FUR + 1 µg/L PbAc); FUR + PbAc (8 mg/kg FUR + 10 µg/L PbAc), and FUR + PbAc (8 mg/kg FUR + 100 µg/L PbAc). Biomarkers of hepatorenal function, oxidative stress, inflammation, DNA damage, and apoptosis were examined. Furan and incrementally Pb exposure increased the levels of hepatorenal biomarkers and oxidative and pro-inflammatory mediators, including lipid peroxidation, reactive oxygen and nitrogen species, and interleukin-1 beta. Increased DNA damage, caspases- 9 and -3, and atypical histoarchitecture of the hepatorenal tissues exemplified furan and Pb treatment-related perturbations. Furthermore, the levels of antioxidants and IL-10 were also suppressed. Furan and Pb dose-dependently exacerbated hepatorenal derangements by altering the redox and inflammatory rheostats, worsened DNA damage, and related apoptotic onset that may potentiate hepatorenal disorders in humans and animals. The findings validate the synergistic effect of furan and Pb in the pathophysiology of kidney and liver disorders.
在人类和动物中,呋喃和 Pb 的无意暴露与肝肾功能异常有关。人们认为这两种化学物质可能协同作用,导致肝和肾损伤。在此背景下,我们研究了呋喃和递增 Pb 暴露对肝肾功能障碍的联合作用。将 Wistar 大鼠(n = 30;150 g)相应地处理 28 天:对照组;呋喃(8 mg/kg)、醋酸铅(100 μg/L)、呋喃+醋酸铅(8 mg/kg 呋喃+1 μg/L 醋酸铅)、呋喃+醋酸铅(8 mg/kg 呋喃+10 μg/L 醋酸铅)和呋喃+醋酸铅(8 mg/kg 呋喃+100 μg/L 醋酸铅)。检查了肝肾功能、氧化应激、炎症、DNA 损伤和细胞凋亡的生物标志物。呋喃和递增 Pb 暴露增加了肝肾功能生物标志物以及氧化和促炎介质的水平,包括脂质过氧化、活性氧和氮物种以及白细胞介素-1β。增加的 DNA 损伤、caspase-9 和 -3 以及肝肾功能组织的非典型组织学结构说明了呋喃和 Pb 处理相关的干扰。此外,抗氧化剂和 IL-10 的水平也受到抑制。呋喃和 Pb 以剂量依赖的方式通过改变氧化还原和炎症变阻器来加剧肝肾功能障碍,加重 DNA 损伤和相关的细胞凋亡起始,这可能加剧人类和动物的肝肾功能障碍。这些发现验证了呋喃和 Pb 在肾脏和肝脏疾病发病机制中的协同作用。